- Home
- VIVS vs TTNP Comparison
VIVS vs TTNP Comparison
Compare VIVS & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVS
- TTNP
- Stock Information
- Founded
- VIVS 2007
- TTNP 1991
- Country
- VIVS United States
- TTNP United States
- Employees
- VIVS N/A
- TTNP N/A
- Industry
- VIVS Biotechnology: Biological Products (No Diagnostic Substances)
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VIVS Health Care
- TTNP Health Care
- Exchange
- VIVS Nasdaq
- TTNP Nasdaq
- Market Cap
- VIVS 4.7M
- TTNP 5.4M
- IPO Year
- VIVS N/A
- TTNP 1996
- Fundamental
- Price
- VIVS $2.51
- TTNP $4.23
- Analyst Decision
- VIVS
- TTNP
- Analyst Count
- VIVS 0
- TTNP 0
- Target Price
- VIVS N/A
- TTNP N/A
- AVG Volume (30 Days)
- VIVS 763.1K
- TTNP 92.5K
- Earning Date
- VIVS 11-07-2025
- TTNP 08-14-2025
- Dividend Yield
- VIVS N/A
- TTNP N/A
- EPS Growth
- VIVS N/A
- TTNP N/A
- EPS
- VIVS N/A
- TTNP N/A
- Revenue
- VIVS $142,000.00
- TTNP N/A
- Revenue This Year
- VIVS $42.38
- TTNP N/A
- Revenue Next Year
- VIVS $15.42
- TTNP N/A
- P/E Ratio
- VIVS N/A
- TTNP N/A
- Revenue Growth
- VIVS 94.52
- TTNP N/A
- 52 Week Low
- VIVS $1.41
- TTNP $3.03
- 52 Week High
- VIVS $21.96
- TTNP $6.43
- Technical
- Relative Strength Index (RSI)
- VIVS 63.18
- TTNP 45.73
- Support Level
- VIVS $1.83
- TTNP $3.58
- Resistance Level
- VIVS $3.10
- TTNP $4.45
- Average True Range (ATR)
- VIVS 0.33
- TTNP 0.37
- MACD
- VIVS 0.06
- TTNP -0.08
- Stochastic Oscillator
- VIVS 57.25
- TTNP 36.93
About VIVS VivoSim Labs Inc. Common Stock
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.